$656 Million is the total value of Bellevue Asset Management AG's 127 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 18.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | Celgene Corporation | $26,037,000 | +4.8% | 217,410 | -5.4% | 3.97% | -2.1% |
| BIIB | Buy | Biogen Inc. | $25,743,000 | +22.9% | 84,030 | +17.1% | 3.92% | +14.8% |
| GILD | Sell | Gilead Sciences, Inc. | $24,298,000 | -2.6% | 240,120 | -5.5% | 3.70% | -9.0% |
| AMGN | Buy | Amgen Inc. | $19,967,000 | +20.3% | 123,000 | +2.5% | 3.04% | +12.4% |
| REGN | Sell | Regeneron Pharmaceuticals, Inc. | $19,760,000 | +9.2% | 36,400 | -6.4% | 3.01% | +2.0% |
| MDT | Sell | Medtronic, Inc. | $19,730,000 | +9.2% | 256,500 | -5.0% | 3.01% | +2.0% |
| ILMN | Buy | Illumina, Inc. | $17,549,000 | +13.9% | 91,425 | +4.3% | 2.67% | +6.4% |
| ABT | Sell | Abbott Laboratories | $17,133,000 | -8.0% | 381,500 | -17.6% | 2.61% | -14.1% |
| MYL | Buy | Mylan Inc. | $17,048,000 | +88.2% | 315,300 | +40.1% | 2.60% | +75.8% |
| BDX | Buy | Becton, Dickinson and Company | $16,191,000 | +32.2% | 105,075 | +13.8% | 2.47% | +23.5% |
| CAH | Buy | Cardinal Health, Inc. | $15,308,000 | +149.1% | 171,480 | +114.4% | 2.33% | +132.7% |
| UNH | UnitedHealth Group Incorporated | $14,117,000 | +1.4% | 120,000 | 0.0% | 2.15% | -5.3% | |
| SYK | Stryker Corporation | $13,077,000 | -1.2% | 140,700 | 0.0% | 1.99% | -7.8% | |
| TEVA | Buy | Teva Pharmaceuticals, Inc.adr | $11,600,000 | +21.4% | 176,720 | +4.4% | 1.77% | +13.4% |
| ESRX | Sell | Express Scripts Holding Company | $10,839,000 | -16.3% | 124,000 | -22.5% | 1.65% | -21.9% |
| ENDP | Buy | Endo International PLC | $10,469,000 | -4.4% | 171,000 | +8.2% | 1.60% | -10.6% |
| EARS | Auris Medical Holding AG | $10,414,000 | +34.8% | 2,169,625 | 0.0% | 1.59% | +26.0% | |
| ZBH | Zimmer Holdings, Inc. | $9,797,000 | +9.2% | 95,500 | 0.0% | 1.49% | +2.1% | |
| ALXN | Alexion Pharmaceuticals, Inc. | $9,423,000 | +22.0% | 49,400 | 0.0% | 1.44% | +14.0% | |
| CVS | Buy | CVS Health Corporation | $9,405,000 | +77.3% | 96,200 | +74.9% | 1.43% | +65.7% |
| LGND | Sell | Ligand Pharmaceuticals Incorporated | $8,851,000 | +8.0% | 81,640 | -14.7% | 1.35% | +0.9% |
| INCY | Buy | Incyte Corporation | $8,568,000 | +0.9% | 79,000 | +2.6% | 1.30% | -5.8% |
| IONS | New | Ionis Pharmaceuticals Inc. | $8,546,000 | – | 138,000 | +100.0% | 1.30% | – |
| MCK | Buy | McKesson Corporation | $8,481,000 | +11.8% | 43,000 | +4.9% | 1.29% | +4.4% |
| BSX | Buy | Boston Scientific Corporation | $8,482,000 | +29.2% | 460,000 | +15.0% | 1.29% | +20.6% |
| VRTX | Sell | Vertex Pharmaceuticals Incorporated | $8,431,000 | -1.9% | 67,000 | -18.8% | 1.28% | -8.3% |
| JAZZ | Buy | Jazz Pharmaceuticals Public Limited Company | $8,434,000 | +13.4% | 60,000 | +7.1% | 1.28% | +5.9% |
| STJ | St. Jude Medical, Inc. | $7,536,000 | -2.1% | 122,000 | 0.0% | 1.15% | -8.5% | |
| CI | Sell | Cigna Corporation | $7,024,000 | -10.3% | 48,000 | -17.2% | 1.07% | -16.2% |
| CNC | Buy | Centene Corporation | $6,952,000 | +540.7% | 105,630 | +428.2% | 1.06% | +498.3% |
| BMRN | BioMarin Pharmaceutical Inc. | $6,809,000 | -0.5% | 65,000 | 0.0% | 1.04% | -7.2% | |
| INSYQ | Buy | Insys Therapeutics, Inc. | $6,642,000 | +11.1% | 232,000 | +10.5% | 1.01% | +3.8% |
| ABC | Buy | AmerisourceBergen Corporation | $6,637,000 | +16.5% | 64,000 | +6.7% | 1.01% | +8.7% |
| PRGO | Buy | Perrigo Company plc | $6,367,000 | +1.2% | 44,000 | +10.0% | 0.97% | -5.5% |
| SHPG | Sell | Shire PLCsponsored adr | $6,318,000 | -0.3% | 30,820 | -0.2% | 0.96% | -6.9% |
| ISRG | Sell | Intuitive Surgical, Inc. | $6,308,000 | +1.3% | 11,550 | -14.8% | 0.96% | -5.4% |
| CHRS | Buy | Coherus BioSciences, Inc | $5,901,000 | +28.0% | 257,000 | +11.7% | 0.90% | +19.5% |
| AET | Aetna Inc. | $5,730,000 | -1.2% | 53,000 | 0.0% | 0.87% | -7.7% | |
| HALO | Buy | Halozyme Therapeutics, Inc. | $5,511,000 | +66.8% | 318,000 | +29.3% | 0.84% | +55.8% |
| EW | Buy | Edwards Lifesciences Corporation | $5,450,000 | -13.9% | 69,000 | +55.1% | 0.83% | -19.6% |
| HUM | Humana, Inc. | $5,355,000 | -0.3% | 30,000 | 0.0% | 0.82% | -6.8% | |
| HZNP | Buy | Horizon Pharma plc | $5,309,000 | +21.8% | 245,000 | +11.4% | 0.81% | +13.8% |
| ALKS | Buy | Alkermes Public Limited Company | $5,199,000 | +50.2% | 65,500 | +11.0% | 0.79% | +40.2% |
| JNJ | Johnson & Johnson | $5,136,000 | +10.0% | 50,000 | 0.0% | 0.78% | +2.9% | |
| BCR | Buy | C.R. Bard, Inc. | $5,115,000 | +12.0% | 27,000 | +10.2% | 0.78% | +4.6% |
| MNKKQ | Sell | Mallinckrodt public limited company | $5,075,000 | -0.8% | 68,000 | -15.0% | 0.77% | -7.3% |
| XENT | Buy | Intersect Ent, Inc. | $5,063,000 | +8.3% | 225,000 | +12.6% | 0.77% | +1.0% |
| EGBN | New | EAGLE PHARMACEUTICALS INC | $4,877,000 | – | 55,000 | +100.0% | 0.74% | – |
| SUPN | Buy | Supernus Pharmaceuticals, Inc. | $4,771,000 | +6.3% | 355,000 | +10.9% | 0.73% | -0.7% |
| CYH | Buy | Community Health Systems, Inc. | $4,628,000 | -33.3% | 174,440 | +7.5% | 0.70% | -37.7% |
| ACHN | Achillion Pharmaceuticals, Inc. | $4,532,000 | +56.2% | 420,000 | 0.0% | 0.69% | +46.1% | |
| LCI | New | Lannett Inc. | $4,312,000 | – | 107,480 | +100.0% | 0.66% | – |
| BAX | Buy | Baxter International Inc. | $4,197,000 | +155.4% | 110,000 | +120.0% | 0.64% | +138.4% |
| ANTM | Anthem, Inc. | $4,183,000 | -0.4% | 30,000 | 0.0% | 0.64% | -7.0% | |
| BMY | Bristol-Myers Squibb Company | $4,127,000 | +16.2% | 60,000 | 0.0% | 0.63% | +8.6% | |
| HCA | Buy | HCA Holdings, Inc. | $4,058,000 | +31.2% | 60,000 | +50.0% | 0.62% | +22.4% |
| NBIX | Neurocrine Biosciences, Inc. | $3,677,000 | +42.2% | 65,000 | 0.0% | 0.56% | +32.7% | |
| NKTR | Sell | Nektar Therapeutics | $3,640,000 | +37.4% | 216,000 | -10.0% | 0.56% | +28.5% |
| CERN | Buy | Cerner Corporation | $3,610,000 | +9.5% | 60,000 | +9.1% | 0.55% | +2.2% |
| PFE | Buy | Pfizer Inc. | $3,551,000 | +33.0% | 110,000 | +29.4% | 0.54% | +24.4% |
| AGIO | Agios Pharmaceuticals, Inc. | $3,506,000 | -8.0% | 54,000 | 0.0% | 0.53% | -14.1% | |
| NVDQ | Novadaq Technologies Inc. | $3,185,000 | +22.1% | 250,000 | 0.0% | 0.48% | +14.1% | |
| MRK | Merck & Co., Inc. | $3,169,000 | +7.0% | 60,000 | 0.0% | 0.48% | 0.0% | |
| HOLX | Hologic, Inc. | $3,134,000 | -1.1% | 81,000 | 0.0% | 0.48% | -7.5% | |
| MASI | Masimo Corporation | $3,113,000 | +7.6% | 75,000 | 0.0% | 0.47% | +0.4% | |
| ARIA | ARIAD Pharmaceuticals, Inc. | $3,094,000 | +7.0% | 495,000 | 0.0% | 0.47% | -0.2% | |
| SGEN | Buy | Seattle Genetics, Inc. | $3,052,000 | +64.9% | 68,000 | +41.7% | 0.46% | +54.0% |
| MDVN | Buy | Medivation, Inc. | $3,045,000 | +36.2% | 63,000 | +19.8% | 0.46% | +27.1% |
| VAR | Varian Medical Systems, Inc. | $2,990,000 | +9.5% | 37,000 | 0.0% | 0.46% | +2.5% | |
| LLY | Lilly Eli & Co. | $2,949,000 | +0.7% | 35,000 | 0.0% | 0.45% | -6.1% | |
| TMO | Thermo Fisher Scientific Inc. | $2,837,000 | +16.0% | 20,000 | 0.0% | 0.43% | +8.3% | |
| NVAX | Novavax, Inc. | $2,727,000 | +18.7% | 325,000 | 0.0% | 0.42% | +10.9% | |
| MGNX | Macrogenics, Inc. | $2,571,000 | +44.6% | 83,000 | 0.0% | 0.39% | +35.2% | |
| QGEN | Buy | Qiagen NV | $2,530,000 | +22.6% | 91,500 | +14.4% | 0.38% | +14.2% |
| CLDX | Celldex Therapeutics, Inc. | $2,509,000 | +48.8% | 160,000 | 0.0% | 0.38% | +38.9% | |
| COO | Cooper Companies Inc. | $2,483,000 | -9.8% | 18,500 | 0.0% | 0.38% | -15.8% | |
| RDUS | New | Radius Health Inc. | $2,462,000 | – | 40,000 | +100.0% | 0.38% | – |
| TFX | Teleflex Incorporated | $2,439,000 | +5.8% | 18,557 | 0.0% | 0.37% | -1.1% | |
| GMED | Globus Medical, Inc.cl a | $2,440,000 | +34.7% | 87,700 | 0.0% | 0.37% | +25.7% | |
| NUVA | Nuvasive, Inc. | $2,435,000 | +12.2% | 45,000 | 0.0% | 0.37% | +4.8% | |
| HCSG | Healthcare Services Group Inc. | $2,267,000 | +3.5% | 65,000 | 0.0% | 0.34% | -3.4% | |
| ALNY | Sell | Alnylam Pharmaceuticals Inc. | $2,259,000 | -12.2% | 24,000 | -25.0% | 0.34% | -18.1% |
| ZLTQ | New | Zeltiq Aesthetics Inc. | $2,140,000 | – | 75,000 | +100.0% | 0.33% | – |
| PRTA | Buy | Prothena Corporation plc | $2,111,000 | +210.4% | 31,000 | +106.7% | 0.32% | +190.1% |
| ICPT | Buy | Intercept Pharmaceuticals, Inc. | $2,016,000 | +39.7% | 13,500 | +55.2% | 0.31% | +30.6% |
| BLUE | Buy | Bluebird Bio, Inc. | $1,862,000 | +6.2% | 29,000 | +41.5% | 0.28% | -0.7% |
| CLVS | Sell | Clovis Oncology, Inc. | $1,838,000 | -63.7% | 52,500 | -4.5% | 0.28% | -66.1% |
| SRCL | Sell | Stericycle, Inc. | $1,809,000 | -35.1% | 15,000 | -25.0% | 0.28% | -39.2% |
| PTCT | New | PTC Therapeutics Inc. | $1,782,000 | – | 55,000 | +100.0% | 0.27% | – |
| INO | Inovio Pharmaceuticals, Inc. | $1,781,000 | +16.3% | 265,000 | 0.0% | 0.27% | +8.4% | |
| WMGI | New | Wright Medical Group Inc. | $1,700,000 | – | 70,309 | +100.0% | 0.26% | – |
| JUNO | Buy | Juno Therapeutics, Inc. | $1,627,000 | +21.1% | 37,000 | +12.1% | 0.25% | +13.2% |
| ACAD | Sell | Acadia Pharmaceuticals, Inc. | $1,604,000 | -17.8% | 45,000 | -23.7% | 0.24% | -23.3% |
| WCG | WellCare Health Plans, Inc. | $1,564,000 | -9.3% | 20,000 | 0.0% | 0.24% | -15.3% | |
| UTHR | United Therapeutics Corporation | $1,456,000 | +19.2% | 9,300 | 0.0% | 0.22% | +11.6% | |
| DVA | Davita Healthcare Partners, Inc. | $1,394,000 | -3.7% | 20,000 | 0.0% | 0.21% | -10.2% | |
| INFI | Buy | Infinity Pharmaceuticals, Inc. | $1,256,000 | +14.3% | 160,000 | +23.1% | 0.19% | +6.7% |
| LH | Laboratory Corporation of America Holdings | $1,236,000 | +13.9% | 10,000 | 0.0% | 0.19% | +6.2% | |
| ANGO | AngioDynamics, Inc. | $1,214,000 | -8.0% | 100,000 | 0.0% | 0.18% | -14.0% | |
| RARE | New | Ultragenyx Pharmaceuticals Inc. | $1,122,000 | – | 10,000 | +100.0% | 0.17% | – |
| ALDR | Sell | Alder Biopharmaceuticals Inc. | $1,090,000 | -22.6% | 33,000 | -23.3% | 0.17% | -27.8% |
| EXEL | Buy | Exelixis, Inc. | $959,000 | +13.9% | 170,000 | +13.3% | 0.15% | +6.6% |
| ESPR | Esperion Therapeutics Inc. | $890,000 | -5.7% | 40,000 | 0.0% | 0.14% | -11.7% | |
| ABBV | Sell | Abbvie Inc. | $889,000 | -39.5% | 15,000 | -44.4% | 0.14% | -43.8% |
| KITE | Sell | Kite Pharma, Inc. | $863,000 | -87.0% | 14,000 | -88.3% | 0.13% | -87.9% |
| IBB | Ishares TRnasdq biotec etf | $846,000 | +11.6% | 2,500 | 0.0% | 0.13% | +4.0% | |
| AFFX | Affymetrix, Inc. | $807,000 | +18.2% | 80,000 | 0.0% | 0.12% | +10.8% | |
| RMD | ResMed Inc. | $805,000 | +5.4% | 15,000 | 0.0% | 0.12% | -1.6% | |
| PODD | Sell | Insulet Corporation | $794,000 | +36.2% | 21,000 | -6.7% | 0.12% | +27.4% |
| IPXL | Impax Laboratories, Inc. | $770,000 | +21.5% | 18,000 | 0.0% | 0.12% | +13.6% | |
| TMH | Team Health Holdings Inc. | $658,000 | -18.8% | 15,000 | 0.0% | 0.10% | -24.2% | |
| MYGN | Sell | Myriad Genetics, Inc. | $604,000 | -51.2% | 14,000 | -57.6% | 0.09% | -54.5% |
| ABUS | Arbutus Biopharm Corporation | $556,000 | -26.9% | 125,000 | 0.0% | 0.08% | -31.5% | |
| JNP | Juniper Pharmaceuticals Inc. | $515,000 | -12.6% | 50,000 | 0.0% | 0.08% | -18.8% | |
| CSII | Cadiovascular Systems Inc. | $454,000 | -4.4% | 30,000 | 0.0% | 0.07% | -10.4% | |
| MNKD | MannKind Corporation | $435,000 | -54.8% | 300,000 | 0.0% | 0.07% | -58.0% | |
| IMGN | Immunomedics, Inc. | $407,000 | +41.3% | 30,000 | 0.0% | 0.06% | +31.9% | |
| ECYT | Sell | Endocyte, Inc. | $401,000 | -44.6% | 100,000 | -36.7% | 0.06% | -48.3% |
| THC | Sell | Tenet Healthcare Corporation | $303,000 | -93.5% | 10,000 | -92.1% | 0.05% | -94.0% |
| XOMA | XOMA Corporation | $299,000 | +76.9% | 225,000 | 0.0% | 0.05% | +64.3% | |
| HTWR | Sell | Heartware International, Inc. | $252,000 | -89.3% | 5,000 | -88.9% | 0.04% | -90.1% |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $221,000 | +34.8% | 22,000 | 0.0% | 0.03% | +25.9% | |
| GERN | Geron Corporation | $218,000 | +75.8% | 45,000 | 0.0% | 0.03% | +65.0% | |
| TBPH | Theravance Biopharma, Inc. | $187,000 | +48.4% | 11,428 | 0.0% | 0.03% | +33.3% | |
| CLDN | Celladon Corporation | $74,000 | +39.6% | 50,000 | 0.0% | 0.01% | +22.2% | |
| AST | Asterias Biotherapeutics, Inc. | $7,000 | 0.0% | 1,875 | 0.0% | 0.00% | 0.0% | |
| BTXWS | New | Biotime Inc.w exp 10/01/2018 | $3,000 | – | 2,294 | +100.0% | 0.00% | – |
| BTX | Exit | Biotime Inc. | $0 | – | -2,294 | -100.0% | 0.00% | – |
| T107PS | Exit | Wright Medical Group Inc. | $0 | – | -10,000 | -100.0% | -0.03% | – |
| Exit | Rewalk Robotics Ltd. | $0 | – | -30,000 | -100.0% | -0.04% | – | |
| THRX | Exit | Theravance, Inc. | $0 | – | -35,000 | -100.0% | -0.04% | – |
| DYAX | Exit | Dyax Corporation | $0 | – | -15,000 | -100.0% | -0.05% | – |
| PEN | Exit | Penumbra Inc. | $0 | – | -10,000 | -100.0% | -0.06% | – |
| ELGX | Exit | Endologix, Inc. | $0 | – | -50,000 | -100.0% | -0.10% | – |
| KANG | Exit | iKang Healthcare Group, Inc.sponsored adr | $0 | – | -75,000 | -100.0% | -0.18% | – |
| UBIO | Exit | Ultra NASDAQ Biotechnologyultrapro nasbio | $0 | – | -35,000 | -100.0% | -0.33% | – |
| XRAY | Exit | DENTSPLY International Inc. | $0 | – | -58,400 | -100.0% | -0.48% | – |
| ZFGN | Exit | Zafgen Inc. | $0 | – | -100,000 | -100.0% | -0.52% | – |
| AKRXQ | Exit | Akorn, Inc. | $0 | – | -112,470 | -100.0% | -0.52% | – |
| ISIS | Exit | Isis Pharmaceuticals, Inc. | $0 | – | -132,000 | -100.0% | -0.87% | – |
| RDY | Exit | Dr. Reddy's Laboratories Limitedadr | $0 | – | -130,000 | -100.0% | -1.36% | – |
| AGN | Exit | Allergan PLC | $0 | – | -50,150 | -100.0% | -2.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Biogen Inc. | 4 | Q4 2015 | 4.2% |
| Celgene Corporation | 4 | Q4 2015 | 4.1% |
| Gilead Sciences, Inc. | 4 | Q4 2015 | 4.1% |
| Medtronic, Inc. | 4 | Q4 2015 | 3.7% |
| Abbott Laboratories | 4 | Q4 2015 | 3.3% |
| Regeneron Pharmaceuticals, Inc. | 4 | Q4 2015 | 3.0% |
| Amgen Inc. | 4 | Q4 2015 | 3.0% |
| Illumina, Inc. | 4 | Q4 2015 | 2.7% |
| UnitedHealth Group Incorporated | 4 | Q4 2015 | 2.3% |
| Stryker Corporation | 4 | Q4 2015 | 2.2% |
View Bellevue Asset Management AG's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Auris Medical Holding AG | February 14, 2018 | 2,169,625 | 4.5% |
View Bellevue Asset Management AG's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-11 |
| 13F-NT | 2022-05-13 |
| 13F-NT | 2022-02-10 |
| 13F-NT | 2021-11-12 |
View Bellevue Asset Management AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.